Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jeffrey M Witkin, Lalit K Golani & Jodi L Smith. (2023) Clinical pharmacological innovation in the treatment of depression. Expert Review of Clinical Pharmacology 16:4, pages 349-362.
Read now
Read now
Articles from other publishers (7)
Marco Di Nicola, Maria Pepe, Silvia Montanari, Maria Chiara Spera, Isabella Panaccione, Alessio Simonetti & Gabriele Sani. (2023) Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes. European Neuropsychopharmacology 70, pages 21-28.
Crossref
Crossref
Kyeong Ju Lee & Yu Jeung Lee. (2023) Adherence to Antidepressants in Korean Elderly Patients with Major Depressive Disorder. Korean Journal of Clinical Pharmacy 33:1, pages 62-69.
Crossref
Crossref
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, Kyu Young Lee, Elin Heldbo Reines, Minah Lee & Yoo Jin Park. (2023) Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea. Frontiers in Psychiatry 14.
Crossref
Crossref
Eduardo Cumbo, Michael Adair, Daniel Oudin Åstrom & Michael Cronquist Christensen. (2023) Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Jill D. Waring, Samantha E. Williams, Angela Stevens, Anja Pogarčić, Joshua S. Shimony, Abraham Z. Snyder, Christopher R. Bowie & Eric J. Lenze. (2023) Combined Cognitive Training and Vortioxetine Mitigates Age-Related Declines in Functional Brain Network Integrity. The American Journal of Geriatric Psychiatry.
Crossref
Crossref
T. S. Sathyanarayana Rao & Chittaranjan Andrade. (2022) Antidepressants and Sexual Dysfunction: Is Vortioxetine Among the Exceptions?. Journal of Psychosexual Health 4:3, pages 155-156.
Crossref
Crossref
N.N. Petrova & A.A. Mukhin. (2022) Mechanisms of action and clinical effects of vortioxetine. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:6, pages 84.
Crossref
Crossref